THE EMERGENCE OF ISONIAZID-RESISTANT CULTURES IN PATIENTS WITH PULMONARY TUBERCULOSIS DURING TREATMENT WITH ISONIAZID ALONE OR ISONIAZID PLUS PAS.

作者
J.B. Selkon,S. Devadatta,K. G. Kulkarni,D.A. Mitchison,A. Narayana,C. N. Nair,K. Ramachandran
出处
期刊:PubMed [National Institutes of Health]
卷期号:31: 273-94 被引量:56
标识
摘要

Previous reports from the Tuberculosis Chemotherapy Centre, Madras, have described a comparison of four regimens (three of isoniazid alone and one of isoniazid plus PAS) in the treatment of pulmonary tuberculosis and an investigation of the serum isoniazid levels in the patients concerned. The present report studies the emergence of isoniazid-resistant organisms in these patients during treatment. All patients with an unsatisfactory response to treatment yielded resistant cultures, showing that the isoniazid dosage was never too low to inhibit sensitive organisms. From the degree of resistance of the first resistant cultures and of the six-month cultures from the patients treated with isoniazid alone it was concluded that resistance emerged in two stages. In the first stage, very earlyin treatment, highly resistant mutant bacilli grew freely whatever the isoniazid dosage, but mutants of lower resistance were prevented from growing to an extent dependent on the peak isoniazid concentration in the serum. Consequently, when the isoniazid dosage was increased the proportion of patients with resistant organisms decreased, since fewer low-resistance strains were able to develop. In the second stage, organisms with relatively low resistance continued to multiply, though still partially inhibited by isoniazid, and became more resistant, particularly in slow inactivators. The first-stage events determined the results of treatment since, once resistance had emerged, its extent was unrelated to the patient's eventual progress. These findings emphasize the importance of early intensive chemotherapy and adjustment of the isoniazid dosage according to peak serum concentrations rather than concentrations measured three or six hours after the dose. Concomitant administration of PAS prevented emergence of isoniazid resistance in many patients and in others delayed its emergence and reduced its degree, possibly because growth in the second stage was slow.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
顾矜应助疯狂阿香采纳,获得30
刚刚
喜悦翰完成签到,获得积分10
刚刚
zhangzhisenn发布了新的文献求助10
刚刚
隐形曼青应助ljl采纳,获得10
刚刚
Zzzzy发布了新的文献求助10
1秒前
科研通AI6.4应助fate采纳,获得10
1秒前
东方巧曼完成签到,获得积分10
1秒前
自由诗筠完成签到,获得积分10
1秒前
凶狠的雁芙完成签到,获得积分10
1秒前
张张完成签到,获得积分10
1秒前
顺利一德发布了新的文献求助10
1秒前
niat完成签到,获得积分10
1秒前
2秒前
111完成签到,获得积分10
2秒前
0015发布了新的文献求助10
2秒前
aloopp发布了新的文献求助10
2秒前
wanci应助积极冰淇淋采纳,获得10
3秒前
3秒前
健壮惋清发布了新的文献求助10
3秒前
洛绮云完成签到,获得积分10
3秒前
眼睛大的靖仇完成签到,获得积分10
3秒前
丫丫完成签到,获得积分10
4秒前
Ly完成签到 ,获得积分10
4秒前
东风完成签到,获得积分10
4秒前
4秒前
冷静紫真完成签到,获得积分10
5秒前
谨慎青枫发布了新的文献求助10
5秒前
壮观的雨泽完成签到,获得积分10
5秒前
学习新思想完成签到,获得积分10
5秒前
大白兔完成签到 ,获得积分10
5秒前
自由诗筠发布了新的文献求助10
5秒前
linger完成签到 ,获得积分10
5秒前
CYH完成签到,获得积分10
6秒前
6秒前
辛勤面包发布了新的文献求助10
6秒前
石头完成签到,获得积分10
6秒前
成就的沛菡完成签到,获得积分10
6秒前
lemon发布了新的文献求助10
6秒前
eiland发布了新的文献求助10
8秒前
8秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Nine new races of Peronospora manshurica found on soybeans in the Midwest 1000
Essentials of Carbohydrate Chemistry and Biochemistry, 4th Edition 600
Organizational Behavior 510
Management and the Arts 510
Matrix Methods in Data Mining and Pattern Recognition Second Edition 510
Eudora Welty and Modern Media 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 化学工程 工程类 有机化学 物理 复合材料 生物化学 内科学 细胞生物学 基因 遗传学 免疫学 冶金 光电子学 癌症研究
热门帖子
关注 科研通微信公众号,转发送积分 7772931
求助须知:如何正确求助?哪些是违规求助? 9315091
关于积分的说明 20343166
捐赠科研通 7358620
什么是DOI,文献DOI怎么找? 3317085
关于科研通互助平台的介绍 2465596
邀请新用户注册赠送积分活动 2332199